Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,797
Closed -$128K 1653
2025
Q4
$128K Sell
4,797
-720
-13% -$21.3K 0.01% 216
2025
Q3
$167K Buy
5,517
+357
+7% +$10.8K 0.02% 160
2025
Q2
$162K Sell
5,160
-114
-2% -$3.77K 0.02% 151
2025
Q1
$202K Buy
5,274
+1,808
+52% +$76.7K 0.02% 128
2024
Q4
$152K Buy
+3,466
New +$152K 0.02% 138

Other funds holding ENOV

McIlrath & Eck's ENOV Position: Q1 2026 in Review

McIlrath & Eck sold out of Enovis (ENOV) in Q1 2026, closing a stake of 4,797 shares — an estimated $128K sold.

McIlrath & Eck first reported a position in ENOV in Q4 2024 and held it in 5 quarters. The position peaked at $202K in Q1 2025. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • McIlrath & Eck reported no remaining Enovis position as of Q1 2026 after selling out during the quarter.
  • McIlrath & Eck sold 4,797 Enovis shares in Q1 2026, an estimated $128K.
  • McIlrath & Eck first reported a position in Enovis in Q4 2024 and held it in 5 quarters.
  • McIlrath & Eck's Enovis position peaked at $202K in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.